Are you
- a recently endorsed Nurse Practitioner (NP) ?
- an endorsed NP seeking increased support ?
- a D&A NP Candidate and / or Transitional NP ?
- a nurse enrolled in a Master of Nursing (Nurse Practitioner) program ?
- an NP who works in other clinical settings with people who use drugs ?
If you sometimes feel that you are sailing in uncharted waters, then you might find this pilot program just what you need as it has been designed with you in mind.
Features of the program
Interactive educational webinars
There will be six sessions beginning in March 2022 and a final session in October 2022.
Evidenced-based practices for people being treated for AOD disorders will be addressed. The integration of Hepatitis C virus education and management, making the full spectrum of evidence-based HCV treatment a part of normal practice during routine NP care delivery, will also be covered.
Peer support sessions
There will be six sessions beginning in March 2022 and a final session in October 2022.
Monthly group-based mentoring
For added support, a group mentoring experience has been built into the program.
There are a lot more details outlined in the Mentee Expression of Interest (see below), but before you read on, you should know that it is FREE!
There is already a lot of interest in this program and places are strictly limited, so you need to be able to commit to it fully before accepting an offer of a position.
Like to know more?
Please read and complete the Expression of Interest that is available to download HERE.
Applications close on January 24th 2022. Final offers will be made in late January / early February 2022.
We are grateful to Abbvie for their support of this program.